# EZETIMIBE AND SIMVASTATIN
> **ANDA211663** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2024-12-10
## Drug
- **FDA Application Number:** ANDA211663
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EZETIMIBE AND SIMVASTATIN
- **Generic name:** Ezetimibe
- **Active ingredients:** EZETIMIBE; SIMVASTATIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SCIEGEN PHARMS
- **First approval:** 2024-12-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211663)
---
*AI Analytics · CC0 1.0*